PolyPid

PolyPid

PolyPid

PolyPid is a clinical stage emerging specialty pharmaceutical company, engaged in research and development of products based on PLEX (PolymerLipid Encapsulation MatriX), a proprietary drug delivery technology.
Raised
$35.4M
Follow us
Alexa global traffic share
Latest funding Show all
$5,300,000
Venture capital (Series UNDISCLOSED) - 2016
$22,000,000
Venture capital (Series D) - 2016
Aurum Ventures Shavit Capital Chaim Hurvitz
Team Size
10+
Employees
Location
Headquarters
PE HUB , FinSMEs

PolyPid raises $50 mln

$22,000,000 Venture capital (Series D)
FinSMEs , NoCamels - Israeli Tech and Innovation News

PolyPid Closes $22M Equity Financing

Health Funding